Hydroxyzine is an antihistaminic drug that is primarily used to treat allergic symptoms, insomnia, anxiety, and nausea caused due to motion sickness. It is two dosage forms: Tablets and intramuscular injections are available in the market. Histamine is a natural chemical present in the body. It can produce allergy symptoms such as itching, runny nose, or sneezing. Antihistaminic drugs reduce the effects of the natural chemical histamine in the body. It also has sedative properties and is therefore used for the treatment of anxiety and tension.
The hydroxyzine market is anticipated to grow during the forecast period owing to various factors. One of the reasons for the growth of this market is the rise in allergic reactions among the target population. More than 20% of people in most developed countries are affected by allergies, making it a highly prevalent condition. Allergy may be caused by genetic or environmental factors. The prevalence of allergies may act as a driving force for the market. There has been an increase in the geriatric population because of the falling fertility rate and higher life expectancy. Since they are more vulnerable to conditions like anxiety, the use of hydroxyzine in this population may help increase the market share. Also, there have been various funds and investments from certain agencies for the analysis of the hydroxyzine drug. This, along with the awareness provided by various healthcare professionals may aid in boosting this market in the upcoming years.
Although the hydroxyzine market is expected to grow in the forecast period, some factors may cause a hindrance to the market. For instance, there are various side effects associated with the use of hydroxyzine. Some of these effects include chest pain, discomfort, difficulty while swallowing, dizziness, fast heartbeat, hives, itching, or skin rash, irregular heart rate, puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue, trouble breathing, unusual tiredness, or weakness. Also, if there is an overdose of hydroxyzine drug, symptoms like decreased responsiveness, seizures, or severe sleepiness may occur. It may also show interactions with other medications if administered during the same period. It is prescribed when the benefits outweigh the risks associated with its administration. This may restrict the growth of this market.
Technology innovations are expected to provide lucrative opportunities for players to increase their market share in the hydroxyzine market. The invention of novel methods for the preparation of hydroxyzine dosage forms and newer devices for their analysis is constantly under action. Various investments in research and development projects are being done, as a result of the increased prevalence of allergy cases. The need to formulate a novel therapeutic drug, with fewer side effects may create remunerative opportunities for key players in the market. For instance, a study has been conducted at the Poitiers University Hospital, France comparing the efficacy of pregabalin and hydroxyzine on the anxiety score of subjects. Various studies and clinical trials are ongoing for discovering alternative uses for hydroxyzine. Such factors are likely to improve the operations of hydroxyzine; thereby, creating opportunities for the upsurge in this market during the forecast period.
Awareness programs leading to increased product adoptionChange AD, a campaign managed collaboratively by Sanofi and Regeneron, raises awareness about atopic dermatitis, a type of inflammation of the skin. They commission the Atopic Dermatitis Global Adolescent & Pediatric Survey, which has been conducted in nearly 13 countries all over the global. The main aim of this campaign is to understand the full impact of atopic dermatitis on the lives of the people suffering from it. They raise awareness about the disease and help support people with AD by addressing bullying or humiliation faced by them.
Segment Overview: By application type: The hydroxyzine market is divided into allergy, anxiety, and tension. Hydroxyzine is an antihistaminic drug. Allergies caused due to the release of histamine in the body can be treated with its help. It is more frequently recommended for skin allergies. Other than this, it is prescribed by doctors for the management of anxiety and panic disorders. It helps to calm the patient before and after the operational procedures.
By age group: The hydroxyzine market is classified as children and adults. In children, it is prescribed for the treatment of allergic reactions and to reduce itching caused by it. The dose is reduced for both oral as well as parenteral routes. In adults, especially in the geriatric population, it is employed for stress and anxiety management.
By dosage form: The hydroxyzine market is categorized as liquid and tablets. The liquid form of hydroxyzine is available as an injectable. Intramuscular injections are used as adjunctive treatment for alcoholism, relieving anxiety and tension during emotional distress, for people with withdrawal symptoms or delirium tremors, and others. The oral dosage form is used for organic disease when anxiety is evident.
By distribution channel: The hydroxyzine market is divided into hospitals pharmacies, retail pharmacies, and online. Intramuscular injections are provided in hospital pharmacies. Retail pharmacies dispense these drugs based on the prescription provided by the doctor.
Competitive analysis and profiles of the major players in the hydroxyzine market, such as Amsa s.p.a. & cosma s.p.a., Calyx chemicals & pharmaceuticals Ltd., IMPAX LABS INC, IPCA Laboratories Ltd, SANDOZ, Siegfried AG, Srikem Laboratories Pvt. Ltd, SYMED LABS LIMITED, Pfizer Inc., and Teikoku seiyaku co. Ltd. are provided in this report. Some other key market players include Chemi spa and UCB Pharma S.A.
Key Market Segments
- By Application
- By Age Group
- By Dosage Form
- By Distribution Channel
- Hospitals Pharmacies
- Retail Pharmacies
- Online
- By Region
- North America
- Europe
- France
- Germany
- Italy
- Spain
- UK
- Russia
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Thailand
- Malaysia
- Indonesia
- Rest of Asia-Pacific
- LAMEA
- Brazil
- South Africa
- Saudi Arabia
- UAE
- Argentina
- Rest of LAMEA
Key Market Players
- IMPAX LABS INC
- Pfizer Inc.
- Siegfried AG
- SYMED LABS LIMITED
- Srikem Laboratories Pvt. Ltd
- teikoku seiyaku co., ltd.
- calyx chemicals & pharmaceuticals ltd.
- amsa s.p.a. & cosma s.p.a.
- SANDOZ
- IPCA Laboratories Ltd